AJP - Gastrointestinal and Liver Physiology, Vol 263, Issue 1 102-G107, Copyright © 1992 by American Physiological Society

ARTICLES

Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway

H. C. Soudah, Y. Lu, W. L. Hasler and C. Owyang
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109.

The mechanism by which physiological concentrations of cholecystokinin (CCK) evoke pancreatic exocrine secretion in humans was investigated. CCK octapeptide (CCK-8) dose dependently increased trypsin and lipase output in healthy humans. Atropine inhibited CCK-8 (10 ng.kg-1.h-1)-stimulated trypsin output by 84.0 +/- 7.7% and lipase output by 78.6 +/- 9.2%. The inhibition with atropine was much less with a CCK-8 dose of 40 ng.kg-1.h-1 (41.8 +/- 6.6% for trypsin and 46.3 +/- 7.3% for lipase). CCK-8 at 10 ng.kg-1.h-1 produced plasma CCK levels similar to postprandial levels (6.0 +/- 1.3 vs. 6.9 +/- 0.8 pM), whereas the 40-ng.kg-1.h-1 dose produced supraphysiological levels (18.4 +/- 3.1 pM). To evaluate if CCK might act via stimulation of cholinergic nerves, in vitro studies were performed using rat pancreas. CCK-8 (10 nM-10 microM) stimulated [3H]acetylcholine release from pancreatic lobules that was blocked by tetrodotoxin, a calcium-free medium, and the CCK antagonist L364,718. In conclusion, CCK-stimulated pancreatic enzyme secretion is dependent on cholinergic neural and noncholinergic pathways. In humans, CCK infusions, which produce plasma CCK levels similar to those seen postprandially, stimulate the pancreas predominantly via a pathway dependent on cholinergic innervation. Correlative in vitro experiments suggest that CCK may act by stimulation of neural acetylcholine release. In contrast, supraphysiological CCK infusions act in part via noncholinergic pathways.

This article has been cited by other articles:

				S. J. Crozier, M. D. Sans, C. H. Lang, L. G. D'Alecy, S. A. Ernst, and J. A. Williams CCK-induced pancreatic growth is not limited by mitogenic capacity in mice Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1148 - G1157. [Abstract] [Full Text] [PDF]

				E. Viard, Z. Zheng, S. Wan, and R. A. Travagli Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion Am J Physiol Gastrointest Liver Physiol, August 1, 2007; 293(2): G493 - G500. [Abstract] [Full Text] [PDF]

				V. Baptista, K. N. Browning, and R. A. Travagli Effects of cholecystokinin-8s in the nucleus tractus solitarius of vagally deafferented rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1092 - R1100. [Abstract] [Full Text] [PDF]

				B. J. Wang and Z. J. Cui How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R666 - R678. [Abstract] [Full Text] [PDF]

				M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF]

				V. Baptista, Z. L. Zheng, F. H. Coleman, R. C. Rogers, and R. A. Travagli Cholecystokinin Octapeptide Increases Spontaneous Glutamatergic Synaptic Transmission to Neurons of the Nucleus Tractus Solitarius Centralis J Neurophysiol, October 1, 2005; 94(4): 2763 - 2771. [Abstract] [Full Text] [PDF]

				E. L. Holicky, E. M. Hadac, X.-Q. Ding, and L. J. Miller Molecular characterization and organ distribution of type A and B cholecystokinin receptors in cynomolgus monkey Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G507 - G514. [Abstract] [Full Text] [PDF]